Review paper

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future

Volume: 12, Issue: 1
Published: Mar 25, 2021
Abstract
The adoptive transfer of natural killer (NK) cells is an emerging therapy in the field of immuno-oncology. In the last 3 decades, NK cells have been utilized to harness the anti-tumor immune response in a wide range of malignancies, most notably with early evidence of efficacy in hematologic malignancies. NK cells are dysfunctional in patients with hematologic malignancies, and their number and function are further impaired by chemotherapy,...
Paper Details
Title
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
Published Date
Mar 25, 2021
Volume
12
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.